All Stories

  1. Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches
  2. Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
  3. Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives
  4. Diagnostic accuracy of carotid intima media thickness in predicting coronary plaque burden on coronary computed tomography angiography in patients with obstructive sleep apnoea
  5. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation
  6. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction
  7. Obstructive sleep apnoea as a cause of nocturnal nondipping blood pressure: recent evidence regarding clinical importance and underlying mechanisms
  8. Obstructive Sleep Apnea
  9. Mild obstructive sleep apnoea: clinical relevance and approaches to management
  10. CrossTalk proposal: Metabolic syndrome causes sleep apnoea
  11. Rebuttal from Alexandros N. Vgontzas, Jordan Gaines, Silke Ryan and Walter T. McNicholas
  12. Obstructive Sleep Apnea and Other Respiratory Disorders in Obesity
  13. Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea
  14. Obstructive Sleep Apnea and Other Respiratory Disorders in Obesity
  15. Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing
  16. Human adipocytes are highly sensitive to intermittent hypoxia induced NF-kappaB activity and subsequent inflammatory gene expression
  17. Obesity and sleep-disordered breathing--when two 'bad guys' meet
  18. Obstructive Sleep Apnea☆
  19. The effect of continuous positive airway pressure therapy on vascular function in obstructive sleep apnea: how much is enough?
  20. Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study
  21. Sleep quality in chronic obstructive pulmonary disease
  22. Sleep history
  23. Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity
  24. Genetics of Cardiovascular Consequences of Obstructive Sleep Apnea Syndrome
  25. Nasal pillows as an alternative interface in patients with obstructive sleep apnoea syndrome initiating continuous positive airway pressure therapy
  26. Sleep Apnoea
  27. The genetics of obstructive sleep apnoea
  28. In Vivo Intermittent Hypoxia Induces NFκB Activity In An Organ-specific Manner
  29. The Effect of Continuous Positive Airway Pressure on C-Reactive Protein Levels in Patients With Obstructive Sleep Apnea Syndrome
  30. Effects of Salmeterol on Sleeping Oxygen Saturation in Chronic Obstructive Pulmonary Disease
  31. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
  32. Modulation of NFκB Signaling during Intermittent Hypoxia by Nitric Oxide.
  33. Serum Nitric Oxide Derivatives in Obstructive Sleep Apnea Syndrome.
  34. Inflammatory Cardiovascular Risk Markers in Obstructive Sleep Apnoea Syndrome
  35. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS
  36. Obstructive Sleep Apnea
  37. Sleep staging using cardiorespiratory signals
  38. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity
  39. Predictors of Decreased Spontaneous Baroreflex Sensitivity in Obstructive Sleep Apnea Syndrome
  40. A critical role for p38 map kinase in NF-κB signaling during intermittent hypoxia/reoxygenation
  41. Predictors of elevated tumour necrosis factor   level in obstructive sleep apnoea syndrome
  42. Predictors of Elevated Nuclear Factor-κB–dependent Genes in Obstructive Sleep Apnea Syndrome
  43. Comparison of baroreflex sensitivity measures for assessing subjects with Obstructive Sleep Apnea
  44. Comparison of baroreflex sensitivity measures for assessing subjects with Obstructive Sleep Apnea
  45. Obstructive sleep apnoea syndrome: Translating science to clinical practice
  46. Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome